Brochures / Flyers

Veeda Lifesciences Logo

Molecular Characterization of Biopharmaceuticals

Explore our Physico-chemical Characterization techniques in characterizing biopharmaceuticals for drug development, including proteins, antibodies, vaccines, and nucleic acid-based drugs using High Resolution Mass Spectrometry (HRMS), Liquid Chromatography (LC), Electrophoretic Mobility...
Start Reading

Integrated Biosimilar Development Solutions

Offering integrated end-to-end Biosimilar Development Solutions for Peptides, Oligonucleotides, Insulin & Analogs, Fusion Proteins & Recombinant Proteins, mAbs, ADCs
Start Reading

Veeda Biopharma’s ZipChip Solutions for Advanced Biopharmaceutical Analysis

Explore Veeda Biopharma’s collaboration with Biobeams and 908 devices for offering first-of-its-kind services on the ZipChip platform. ZipChip is a sophisticated platform that enables highly advanced and efficient analysis, specifically...
Start Reading

Our Infrastructure for Biopharma Services

Discover how Veeda Biopharma leverages its state-of-the-art infrastructure to accelerate development programs across diverse biopharmaceutical solutions such as Analytics & Characterization, Bioprocess Development, Discovery Biology, and Clinical Bioanalysis.
Start Reading

Navigating NCE Development

Explore Veeda's Integrated NCE Clinical Development & Bioanalytical Solutions for global Pharmaceutical and Bio-Pharmaceutical Companies.
Start Reading
Olaparib-Brochure

Olaparib – An Overview of PARP Inhibitors and Clinical Trials

Learn more about Veeda's expertise in designing efficient protocols, optimizing patient recruitment, ensuring regulatory compliance, and maximizing the potential of Olaparib's clinical data. We aim to collaborate with global Pharma...
Start Reading

From Insulins to GLP-1 Receptors: Preparing for the Next Wave of Off-Patent Molecules

Veeda Group has a track record of supporting the development of key diabetic drugs, including Insulin, Liraglutide, Semaglutide, and Sitagliptin. As a trusted partner having a diverse portfolio of 12...
Start Reading

Inhalation Drugs Nearing Patent Expiry

Integrated Services Spanning the Full Spectrum of Drug Development Stages
Start Reading
Accelerating-Complex-Drug

Accelerating Complex Drug Development through the 505(b)(2) Pathway

Start Reading
injectable-flyer

Injectable Drug Development Support

Complete Solutions for Injectable Drugs Nearing Patent Expiry: Ensuring Seamless Development & Market Readiness
Start Reading
Peptide-Carousel

Peptide Analysis

Employing a Comprehensive Array of Techniques and Methods for the Accurate Quantification and Analysis of Peptides
Start Reading
ACD

Streamlining Biotherapeutic Development: Analytics and Characterization Solutions

Preferred solution partner for physico-chemical, structural characterization and analytical CMC support for broad range of biotherapeutics ranging from peptides, oligos, recombinant-conjugated-fusion protein, monoclonal antibodies (mAbs), bispecific, antibody (Ab) fragments, antibody-drug...
Start Reading